Search
Search
About
Log in
Join
Experiences with
Antithyroid
Posts
Communities
131 public posts
Filter results
Info for People with Graves'/Hyperthyroidism
The full leaflet is available here: https://www.btf-thyroid.org/
antithyroid
-drug-therapy-to-treat-hyperthyroidismleaflet
The full leaflet is available here: https://www.btf-thyroid.org/
antithyroid
-drug-therapy-to-treat-hyperthyroidismleaflet
Valarian
in
Thyroid UK
4 years ago
Agranulocytosis
Here is some more info: https://www.btf-thyroid.org/
antithyroid
-drug-therapy-to-treat-hyperthyroidismleaflet It's important you understand this - and you should have been told - but very unlikely to cause you a problem.
Here is some more info: https://www.btf-thyroid.org/
antithyroid
-drug-therapy-to-treat-hyperthyroidismleaflet It's important you understand this - and you should have been told - but very unlikely to cause you a problem.
Valarian
in
Thyroid UK
4 years ago
High Free T4
November 4, 2019 TSH 2.07 uIU/mL T4 - 1.87 THYROXINE13.38 ug/dL(4.60 - 12.00ug/dL) T3 UPTAKE0.93(0.76 - 1.25) FREE THYROXINE INDEX(12.444.40 - 11.40) TRIIODOTHYYRONINE1.11 ng/mL(0.80 - 2.00 ng/mL)
ANTITHYROID
PEROXIDA15.5 IU/mL(<=8.9 IU/mL) 12:57pm 112 mcg Levoxyl everyday September 26, 2019 TSH 4.03
November 4, 2019 TSH 2.07 uIU/mL T4 - 1.87 THYROXINE13.38 ug/dL(4.60 - 12.00ug/dL) T3 UPTAKE0.93(0.76 - 1.25) FREE THYROXINE INDEX(12.444.40 - 11.40) TRIIODOTHYYRONINE1.11 ng/mL(0.80 - 2.00 ng/mL)
ANTITHYROID
PEROXIDA15.5 IU/mL(<=8.9 IU/mL) 12:57pm 112 mcg Levoxyl everyday September 26, 2019 TSH 4.03
wsn104
in
Thyroid UK
4 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Hypothyroidism to Graves' disease and late appearance of pretibial myxoedema from The Lancet
earlier, he had been diagnosed with autoimmune hypothyroidism after he began to gain weight and complained of feeling tired: his thyroid-stimulating hormone (TSH) concentration was raised at 83 mIU/L (normal range 0·3–4·6), free thyroxine (T4) concentration was 5·9 pmol/L (normal range 10–23), and the
antithyroid
earlier, he had been diagnosed with autoimmune hypothyroidism after he began to gain weight and complained of feeling tired: his thyroid-stimulating hormone (TSH) concentration was raised at 83 mIU/L (normal range 0·3–4·6), free thyroxine (T4) concentration was 5·9 pmol/L (normal range 10–23), and the
antithyroid
holyshedballs
in
Thyroid UK
5 years ago
Patients treated for hyperthyroidism are at increased risk of becoming obese: findings from a large prospective secondary care cohort
Next, we investigated the effect of treatment with
antithyroid
drug alone in regard to
antithyroid
drug with radioiodine therapy. We modelled the longitudinal weight data in relation to the treatment pathway to thyroid function and the need for long-term thyroxine replacement.
Next, we investigated the effect of treatment with
antithyroid
drug alone in regard to
antithyroid
drug with radioiodine therapy. We modelled the longitudinal weight data in relation to the treatment pathway to thyroid function and the need for long-term thyroxine replacement.
helvella
Thyroid UK
in
Thyroid UK
5 years ago
Long term antithyroid medication
In patients hoping to avoid ablative therapy, continuous
antithyroid
drug therapy for >5 years is reasonable.”
In patients hoping to avoid ablative therapy, continuous
antithyroid
drug therapy for >5 years is reasonable.”
Coconutty
in
Thyroid UK
5 years ago
GRAVES AND THYROTOXICOSIS : NEURAL AND MENTAL CHANGES
The patient was treated for one month with
antithyroid
drugs and then given 2.7 mCi 131I. Because of continued hyperthyroidism, the patient was retreated with 3.2 mCi 131I seven months after the initial treatment.
The patient was treated for one month with
antithyroid
drugs and then given 2.7 mCi 131I. Because of continued hyperthyroidism, the patient was retreated with 3.2 mCi 131I seven months after the initial treatment.
ling
in
Thyroid UK
5 years ago
GRAVES : DEVELOPMENT OF THE CLINICAL PICTURE AND THE COURSE OF THE DISEASE
During the course of therapy, the 20-minute technetium uptake test was repeatedly measured while the patient received both
antithyroid
drugs and suppressive doses of T3; suppressibility of the thyroid gradually fell to the normal range.
During the course of therapy, the 20-minute technetium uptake test was repeatedly measured while the patient received both
antithyroid
drugs and suppressive doses of T3; suppressibility of the thyroid gradually fell to the normal range.
ling
in
Thyroid UK
5 years ago
Indefinite antithyroid drug therapy in toxic Graves’ disease: What are the cons
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830376/ Whilst I don't agree especially with the cost effectiveness bits comparing ATD therapy to RAI or TT, this piece is chocked full of details about ATD, RAI, TT. Worth a read since many of us always wonder how long we can go on with Graves on ATD therapy
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830376/ Whilst I don't agree especially with the cost effectiveness bits comparing ATD therapy to RAI or TT, this piece is chocked full of details about ATD, RAI, TT. Worth a read since many of us always wonder how long we can go on with Graves on ATD therapy
ling
in
Thyroid UK
5 years ago
Thyroid eye disease (TED) symptoms, diagnosis and treatment options.
Neither thyroidectomy (typically partial) nor
antithyroid
drugs influence the course of the orbitopathy. 17.
Neither thyroidectomy (typically partial) nor
antithyroid
drugs influence the course of the orbitopathy. 17.
ling
in
Thyroid UK
5 years ago
Antithyroid Drug Therapy for Graves' Disease and Implications for Recurrence
Definitely worth a read! https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424485/ Many significant nuggets of info relating to Graves, though the piece focuses primarily on the implications for recurrence after ATD withdrawal
Definitely worth a read! https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424485/ Many significant nuggets of info relating to Graves, though the piece focuses primarily on the implications for recurrence after ATD withdrawal
ling
in
Thyroid UK
5 years ago
Personalised immunomodulating treatments forGraves’ disease: fact or fiction?
Treatment strategies today mainly focus on suppression of thyroid hormone production by use of
antithyroid
drugs or radio-iodine, but neglect the underlying immunological mechanisms.
Treatment strategies today mainly focus on suppression of thyroid hormone production by use of
antithyroid
drugs or radio-iodine, but neglect the underlying immunological mechanisms.
holyshedballs
in
Thyroid UK
5 years ago
Graves' Disease: Can It Be Cured?
Discontinuation of
antithyroid
drugs is followed by 50% recurrences within 4 years; before starting therapy the risk of recurrences can be estimated with the Graves' Recurrent Events After Therapy (GREAT) score.
Discontinuation of
antithyroid
drugs is followed by 50% recurrences within 4 years; before starting therapy the risk of recurrences can be estimated with the Graves' Recurrent Events After Therapy (GREAT) score.
helvella
Thyroid UK
in
Thyroid UK
5 years ago
Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study An abstract
Compared with patients in the
antithyroid
drug group, mortality was lower among those in radioiodine group A (HR 0·50, 95% CI 0·29–0·85), but not for those in radioiodine group B (HR 1·51, 95% CI 0·96–2·37).
Compared with patients in the
antithyroid
drug group, mortality was lower among those in radioiodine group A (HR 0·50, 95% CI 0·29–0·85), but not for those in radioiodine group B (HR 1·51, 95% CI 0·96–2·37).
holyshedballs
in
Thyroid UK
5 years ago
Thyroidectomy Versus Medical Management for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms: A Randomized Trial
Patients: 150 patients aged 18 to 79 years with persistent Hashimoto-related symptoms despite euthyroid status while receiving hormone replacement therapy and with serum
antithyroid
peroxidase (anti-TPO) antibody titers greater than 1000 IU/mL.
Patients: 150 patients aged 18 to 79 years with persistent Hashimoto-related symptoms despite euthyroid status while receiving hormone replacement therapy and with serum
antithyroid
peroxidase (anti-TPO) antibody titers greater than 1000 IU/mL.
holyshedballs
in
Thyroid UK
5 years ago
GUIDELINES FOR THE MANAGEMENT OF THYROTOXICOSIS
Very comprehensive 30-page info, especially for those newly diagnosed and info for those wondering if its possible to remain on
antithyroid
drugs long term.
Very comprehensive 30-page info, especially for those newly diagnosed and info for those wondering if its possible to remain on
antithyroid
drugs long term.
ling
in
Thyroid UK
5 years ago
Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study
Abstract BACKGROUND: Graves' disease is routinely treated with
antithyroid
drugs, radioiodine, or surgery, but whether the choice of initial therapy influences long-term outcomes is uncertain.
Abstract BACKGROUND: Graves' disease is routinely treated with
antithyroid
drugs, radioiodine, or surgery, but whether the choice of initial therapy influences long-term outcomes is uncertain.
helvella
Thyroid UK
in
Thyroid UK
5 years ago
Thyroidectomy Versus Medical Management for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms: A Randomized Trial
Patients: 150 patients aged 18 to 79 years with persistent Hashimoto-related symptoms despite euthyroid status while receiving hormone replacement therapy and with serum
antithyroid
peroxidase (anti-TPO) antibody titers greater than 1000 IU/mL.
Patients: 150 patients aged 18 to 79 years with persistent Hashimoto-related symptoms despite euthyroid status while receiving hormone replacement therapy and with serum
antithyroid
peroxidase (anti-TPO) antibody titers greater than 1000 IU/mL.
PR4NOW
in
Thyroid UK
5 years ago
Thyroidectomy Versus Medical Management for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms: A Randomized Trial
[/i] [i]Patients:[/i] [i]150 patients aged 18 to 79 years with persistent Hashimoto-related symptoms despite euthyroid status while receiving hormone replacement therapy and with serum
antithyroid
peroxidase (anti-TPO) antibody titers greater than 1000 IU/mL.
[/i] [i]Patients:[/i] [i]150 patients aged 18 to 79 years with persistent Hashimoto-related symptoms despite euthyroid status while receiving hormone replacement therapy and with serum
antithyroid
peroxidase (anti-TPO) antibody titers greater than 1000 IU/mL.
helvella
Thyroid UK
in
Thyroid UK
5 years ago
Clinical Utility of TSH Receptor Antibodies (TRAb)
TRAb can accurately predict short-term relapses of hyperthyroidism after a course of
antithyroid
drugs but are less effective in predicting long-term relapses or remissions. 9. GD affects many organ systems either by the autoimmune process or as a complication of thyrotoxicosis.
TRAb can accurately predict short-term relapses of hyperthyroidism after a course of
antithyroid
drugs but are less effective in predicting long-term relapses or remissions. 9. GD affects many organ systems either by the autoimmune process or as a complication of thyrotoxicosis.
ling
in
Thyroid UK
5 years ago
1
2
3
4
...
7
Next page
Filter results
Clear filters
Posted in
All communities
Thyroid UK
122 results
Pernicious Anaemia Society
3 results
Graves Disease Support
2 results
View top 10 communities
Sort by
Most Relevant
Newest